Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from HUM

Humana Gains Despite Medicare Advantage Losses—What’s the Catch?

Humana is the second largest health insurance provider of Medicare Advantage (MA) plans sounding the alarms of rising medical costs but will now cut 10%

MarketBeat

Humana Stock: Is Wall Street Bullish or Bearish?

Humana has underperformed the broader market by a large margin over the past year and analysts remain cautiously bullish on the stock’s prospects.

Barchart

Humana's Quarterly Earnings Preview: What You Need to Know

Humana is set to release its fourth-quarter results later this month, with analysts anticipating a significant drop in earnings.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Is Humana Stock Underperforming the S&P 500?

Humana has substantially underperformed the S&P 500 over the past year and analysts remain cautiously bullish on the stock’s prospects.

Barchart

UnitedHealth Rises On Medicare Star Ratings Ruling; Humana Rallies

UnitedHealth rose after a federal judge ordered a rerating of the Dow Jones giant's Medicare Star Ratings.

Investors Business Daily

Humana Stock: Analyst Estimates & Ratings

Despite Humana underperforming the broader market over the past year, Wall Street analysts remain moderately bullish on the stock’s prospects.

Barchart

The Listeners on BBC One review: Rebecca Hall is a revelation as a woman pushed to the brink by 'the Hum'

4/5 This horror-inflected four-parter is a hallucinatory, nightmarish drama exploring mystery and conspiracy

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

‘It brought me to my knees’: The Hum – a mysterious phenomenon that’s baffled the world for decades

IN FOCUS: It’s thought that 4 per cent of the global population is plagued by a persistent, rumbling sound in their ears – the source of which is a total enigma. Ellie Harrison speaks to the people who’ve been trying to get to the bottom of a noise that has…

The Independent UK

Bitcoin at record. Stock movers: Coinbase, Tesla, Cigna, Humana

Here are the stocks making the biggest market moves midday.

The Street

Humana's Q3 2024 Earnings: What to Expect

Humana is expected to release its fiscal third-quarter earnings this month, and analysts project a double-digit profit decline.

Barchart

Cigna Restarts Talks To Buy Fallen Star Humana; 2024 Election Is Key

Cigna-Humana merger talks are back on, nearly one year after the first try. The price may be more affordable after CI stock outperformed, while HUM struggled.

Investors Business Daily

Humana stock higher on key merger report after Medicare Advantage hit

Big Medicare changes are pressuring the country's biggest health insurance groups.

The Street

Midday stock movers: Nike, Tesla, Humana

Here are the stocks making the biggest market moves midday.

The Street

Humana hit by troubling Medicare Advantage change

This is what could happen next to Humana shares.

The Street

Get all your
news in one place.

100’s of premium titles.
One news app.

Kiplinger

Humana Stock Sinks on Weak Medicare Star Ratings: What to Know

Humana stock is spiraling Wednesday after the CMS provided preliminary Star Ratings data for the insurer's 2025 Medicare Advantage plans.

Investors Business Daily

Humana Stock Dives On Medicare Ratings; UnitedHealth Tries To Bounce

Humana is diving due to a star-ratings cut for Medicare Advantage plans that will slam 2026 results. UnitedHealth stock is trying to rise.

Barchart

How Is Humana's Stock Performance Compared to Other Healthcare Stocks?

Humana underperformed the broader healthcare sector, but Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Do Wall Street Analysts Like Humana Stock?

Despite Humana underperforming the broader market over the past year, Wall Street analysts remain moderately bullish on the stock’s prospects.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

UnitedHealth Earnings Beat Despite Hack Costs; UNH Stock Extends Trump Rally

UnitedHealth earnings beat estimates Tuesday. UNH stock gained more ground after rising Monday on growing odds that ex-President Donald Trump will win.

Barchart

How Is Centene's Stock Performance Compared to Other Healthcare Stocks?

Centene has underperformed other healthcare stocks over the past three months, but analysts are optimistic about the stock’s prospects.

Barchart

Humana Stock: Is HUM Outperforming the Healthcare Sector?

Humana has recently outperformed the Healthcare sector, and Wall Street analysts are moderately optimistic about the stock’s prospects.

Barchart

Is HCA Healthcare Stock Outperforming the Dow?

HCA Healthcare has consistently surpassed the Dow Jones Industrial Average, and analysts are highly optimistic about its prospects.

Barchart

Is Elevance Health Stock Outperforming the S&P 500?

Elevance Health has outperformed the S&P 500 this year, and analysts remain optimistic about the stock's prospects due to its strong market presence and robust financial performance.

Metal Hammer

"Thumps to the back of the head are tempered by prog, synths, sax and slowcore." Doom champions Pallbearer branch out on emotionally devastating new album Mind Burns Alive

After dipping their toes in the prog pool with 2020's Forgotten Days, Arkansas doom-mongers Pallbearer embrace experimental sounds with new album Mind Burns Alive

Investors Business Daily

CVS Health Dives To 3-Year Low On Medicare Cost Surge

CVS Health earnings tumbled more than expected on a surge in Medicare costs due to higher utilization. CVS stock dived, weighing on UNH and HUM.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.